Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Otorhinolaryngology

  Free Subscription


Articles published in Head Neck

Retrieve available abstracts of 146 articles:
HTML format
Text format



Single Articles


    August 2017
  1. DE BREE R, Wolf GT, de Keizer B, Nixon IJ, et al
    Response assessment after induction chemotherapy for head and neck squamous cell carcinoma: From physical examination to modern imaging techniques and beyond.
    Head Neck. 2017 Aug 17. doi: 10.1002/hed.24883.
    PubMed     Text format     Abstract available


  2. KAWADA T, Takahashi H, Sakakura K, Ida S, et al
    Circulating tumor cells in patients with head and neck squamous cell carcinoma: Feasibility of detection and quantitation.
    Head Neck. 2017 Aug 17. doi: 10.1002/hed.24893.
    PubMed     Text format     Abstract available


  3. FANELLI MF, Oliveira TB, Braun AC, Corassa M, et al
    Evaluation of incidence, significance, and prognostic role of circulating tumor microemboli and transforming growth factor-beta receptor I in head and neck cancer.
    Head Neck. 2017 Aug 17. doi: 10.1002/hed.24899.
    PubMed     Text format     Abstract available


  4. LACCOURREYE O, Bonfils P, Malinvaud D, Menard M, et al
    Survival and laryngeal preservation tradeoff in advanced laryngeal cancer: From the otorhinolaryngology patient to the managing physician.
    Head Neck. 2017 Aug 8. doi: 10.1002/hed.24833.
    PubMed     Text format     Abstract available


  5. KRAAIJENGA SAC, Molen LV, Stuiver MM, Takes RP, et al
    Efficacy of a novel swallowing exercise program for chronic dysphagia in long-term head and neck cancer survivors.
    Head Neck. 2017 Aug 2. doi: 10.1002/hed.24710.
    PubMed     Text format     Abstract available


  6. ASTRUP GL, Rustoen T, Hofso K, Gran JM, et al
    Symptom burden and patient characteristics: Association with quality of life in patients with head and neck cancer undergoing radiotherapy.
    Head Neck. 2017 Aug 2. doi: 10.1002/hed.24875.
    PubMed     Text format     Abstract available


    July 2017
  7. GREEN R, Macmillan MT, Tikka T, Bruce L, et al
    Analysis of the incidence and factors predictive of outcome in patients with head and neck cancer with pulmonary nodules.
    Head Neck. 2017 Jul 25. doi: 10.1002/hed.24885.
    PubMed     Text format     Abstract available


  8. KO HC, Chen S, Wieland AM, Yu M, et al
    Clinical outcomes for patients presenting with N3 head and neck squamous cell carcinoma: Analysis of the National Cancer Database.
    Head Neck. 2017 Jul 24. doi: 10.1002/hed.24881.
    PubMed     Text format     Abstract available


  9. MALIK A, Sahu A, Singh SP, Deshmukh A, et al
    In vivo Raman spectroscopy-assisted early identification of potential second primary/recurrences in oral cancers: An exploratory study.
    Head Neck. 2017 Jul 24. doi: 10.1002/hed.24884.
    PubMed     Text format     Abstract available


  10. MARINA M, Ceda GP, Corcione L, Sgargi P, et al
    Size of thyroid carcinoma by histotype and variants: A population-based study in a mildly iodine-deficient area.
    Head Neck. 2017 Jul 24. doi: 10.1002/hed.24877.
    PubMed     Text format     Abstract available


  11. CZERWONKA L, Bissada E, Goldstein DP, Wood RE, et al
    High-resolution cone-beam computed tomography for assessment of bone invasion in oral cancer: Comparison with conventional computed tomography.
    Head Neck. 2017 Jul 12. doi: 10.1002/hed.24858.
    PubMed     Text format     Abstract available


  12. CHENG CT, Lin CY, Hung-Chun Cheng S, Lin YP, et al
    Survival benefit of surgical approach for advanced oropharyngeal and hypopharyngeal cancer: A retrospective analysis.
    Head Neck. 2017 Jul 10. doi: 10.1002/hed.24869.
    PubMed     Text format     Abstract available


  13. CHANG PH, Yeh KY, Wang CH, Chen EY, et al
    Impact of the pretreatment Glasgow prognostic score on treatment tolerance, toxicities, and survival in patients with advanced head and neck cancer undergoing concurrent chemoradiotherapy.
    Head Neck. 2017 Jul 7. doi: 10.1002/hed.24853.
    PubMed     Text format     Abstract available


  14. FLETCHER KT, Gal TJ, Ebelhar AJ, Valentino J, et al
    Prognostic indicators and survival in salvage surgery for laryngeal cancer.
    Head Neck. 2017 Jul 6. doi: 10.1002/hed.24860.
    PubMed     Text format     Abstract available


  15. SHAH-BECKER S, Pennock M, Sinoway L, Goldenberg D, et al
    Baroreceptor reflex failure: Review of the literature and the potential impact on patients with head and neck cancer.
    Head Neck. 2017 Jul 4. doi: 10.1002/hed.24857.
    PubMed     Text format     Abstract available


    June 2017
  16. DUPREZ F, Berwouts D, De Neve W, Bonte K, et al
    Distant metastases in head and neck cancer.
    Head Neck. 2017 Jun 26. doi: 10.1002/hed.24687.
    PubMed     Text format     Abstract available


  17. REID PA, Wilson P, Li Y, Marcu LG, et al
    Current understanding of cancer stem cells: Review of their radiobiology and role in head and neck cancers.
    Head Neck. 2017 Jun 23. doi: 10.1002/hed.24848.
    PubMed     Text format     Abstract available


  18. BEECHER S, Wrafter PF, Joyce CW, Regan PJ, et al
    High-risk squamous cell carcinoma of the ear - A potential role for sentinel node biopsy.
    Head Neck. 2017 Jun 22. doi: 10.1002/hed.24843.
    PubMed     Text format     Abstract available


  19. MASSA ST, Cass LM, Osazuwa-Peters N, Christopher KM, et al
    Decreased cancer-independent life expectancy in the head and neck cancer population.
    Head Neck. 2017 Jun 22. doi: 10.1002/hed.24850.
    PubMed     Text format     Abstract available


  20. VILASECA I, Valls-Mateus M, Nogues A, Lehrer E, et al
    Usefulness of office examination with narrow band imaging for the diagnosis of head and neck squamous cell carcinoma and follow-up of premalignant lesions.
    Head Neck. 2017 Jun 22. doi: 10.1002/hed.24849.
    PubMed     Text format     Abstract available


  21. TING Y, Chee J, Charn TC, Loh KS, et al
    Prognostic significance of cystic lymph nodal metastasis in nasopharyngeal carcinoma.
    Head Neck. 2017 Jun 22. doi: 10.1002/hed.24844.
    PubMed     Text format     Abstract available


  22. BARBER B, Harris J, Shillington C, Rychlik S, et al
    Efficacy of a high-observation protocol in major head and neck cancer surgery: A prospective study.
    Head Neck. 2017 Jun 20. doi: 10.1002/hed.24599.
    PubMed     Text format     Abstract available


  23. ESKANDER A, Mifsud M, Irish J, Gullane P, et al
    Overview of surgery for laryngeal and hypopharyngeal cancer in Ontario, 2003-2010.
    Head Neck. 2017 Jun 7. doi: 10.1002/hed.24787.
    PubMed     Text format     Abstract available


  24. TAMJID B, Phan P, John T, Mitchell P, et al
    Outcomes for patients with synchronous and metachronous primary lung cancer after diagnosis of head and neck cancer.
    Head Neck. 2017 Jun 7. doi: 10.1002/hed.24751.
    PubMed     Text format     Abstract available


  25. MOHANTI BK, Thakar A, Kaur J, Bahadur S, et al
    Postoperative radiotherapy dose requirement in standard combined-modality practice for head and neck squamous cell carcinoma: Analysis of salient surgical and radiotherapy parameters in 2 cohorts.
    Head Neck. 2017 Jun 6. doi: 10.1002/hed.24836.
    PubMed     Text format     Abstract available


  26. SAITO Y, Omura G, Yasuhara K, Rikitake R, et al
    Prognostic value of lymphovascular invasion of the primary tumor in hypopharyngeal carcinoma after total laryngopharyngectomy.
    Head Neck. 2017 Jun 5. doi: 10.1002/hed.24705.
    PubMed     Text format     Abstract available


  27. D'SOUZA W, Pradhan S, Saranath D
    Multiple single nucleotide polymorphism analysis and association of specific genotypes in FHIT, SAMD4A, and ANKRD17 in Indian patients with oral cancer.
    Head Neck. 2017 Jun 5. doi: 10.1002/hed.24798.
    PubMed     Text format     Abstract available


    May 2017
  28. MEZI S, Chiappetta C, Carletti R, Nardini A, et al
    Clinical significance of epithelial-to-mesenchymal transition in laryngeal carcinoma: its role in the different subsites.
    Head Neck. 2017 May 31. doi: 10.1002/hed.24838.
    PubMed     Text format     Abstract available


  29. MARUCCI L, Farneti A, Di Ridolfi P, Pinnaro P, et al
    Double-blind randomized phase III study comparing a mixture of natural agents versus placebo in the prevention of acute mucositis during chemoradiotherapy for head and neck cancer.
    Head Neck. 2017 May 31. doi: 10.1002/hed.24832.
    PubMed     Text format     Abstract available


  30. MIFSUD M, Eskander A, Irish J, Gullane P, et al
    Evolving trends in head and neck cancer epidemiology: Ontario, Canada 1993-2010.
    Head Neck. 2017 May 30. doi: 10.1002/hed.24829.
    PubMed     Text format     Abstract available


  31. HONDA K, Asato R, Tsuji J, Miyazaki M, et al
    Oncologic safety of cervical nerve preservation in neck dissection for head and neck cancer.
    Head Neck. 2017 May 30. doi: 10.1002/hed.24826.
    PubMed     Text format     Abstract available


  32. ZAIRIS S, Margalit DN, Royce TJ, Powlis WD, et al
    Prospective analysis of radiation oncology image and plan-driven peer review for head and neck cancer.
    Head Neck. 2017 May 17. doi: 10.1002/hed.24800.
    PubMed     Text format     Abstract available


  33. LEE JH, Hwang Y, Song RY, Yi JW, et al
    Relationship between iodine levels and papillary thyroid carcinoma: A systematic review and meta-analysis.
    Head Neck. 2017 May 17. doi: 10.1002/hed.24797.
    PubMed     Text format     Abstract available


  34. SEKINE T, Barbosa FG, Delso G, Burger IA, et al
    Local resectability assessment of head and neck cancer: Positron emission tomography/MRI versus positron emission tomography/CT.
    Head Neck. 2017 May 13. doi: 10.1002/hed.24783.
    PubMed     Text format     Abstract available


  35. ERKAN S, Savundra JM, Wood B, Acharya AN, et al
    Clinical perineural invasion of the trigeminal and facial nerves in cutaneous head and neck squamous cell carcinoma: Outcomes and prognostic implications of multimodality and salvage treatment.
    Head Neck. 2017 May 5. doi: 10.1002/hed.24607.
    PubMed     Text format     Abstract available


  36. WEISS BG, Ihler F, Wolff HA, Schneider S, et al
    Transoral laser microsurgery for treatment for hypopharyngeal cancer in 211 patients.
    Head Neck. 2017 May 5. doi: 10.1002/hed.24814.
    PubMed     Text format     Abstract available


  37. HINSON AM, Massoll NA, Jolly LA, Stack BC Jr, et al
    Structural alterations in tumor-draining lymph nodes before papillary thyroid carcinoma metastasis.
    Head Neck. 2017 May 3. doi: 10.1002/hed.24807.
    PubMed     Text format     Abstract available


    April 2017
  38. AGRAWAL N, Evasovich MR, Kandil E, Noureldine SI, et al
    Indications and extent of central neck dissection for papillary thyroid cancer: An American Head and Neck Society Consensus Statement.
    Head Neck. 2017 Apr 27. doi: 10.1002/hed.24715.
    PubMed     Text format     Abstract available


  39. CHANG PH, Yeh KY, Wang CH, Chen EY, et al
    Impact of metformin on patients with advanced head and neck cancer undergoing concurrent chemoradiotherapy.
    Head Neck. 2017 Apr 27. doi: 10.1002/hed.24793.
    PubMed     Text format     Abstract available


  40. LIU SY, Feng IJ, Wu YW, Chen CY, et al
    Implication for second primary cancer from visible oral and oropharyngeal premalignant lesions in betel-nut chewing related oral cancer.
    Head Neck. 2017 Apr 6. doi: 10.1002/hed.24777.
    PubMed     Text format     Abstract available


    March 2017
  41. TIGHE DF, Thomas AJ, Sassoon I, Kinsman R, et al
    Developing a risk stratification tool for audit of outcome after surgery for head and neck squamous cell carcinoma.
    Head Neck. 2017 Mar 29. doi: 10.1002/hed.24769.
    PubMed     Text format     Abstract available


  42. RIDDER M, Klop M, Hamming-Vrieze O, Boer J, et al
    Unknown primary head and neck squamous cell carcinoma in the era of fluorodeoxyglucose-positron emission tomography/CT and intensity-modulated radiotherapy.
    Head Neck. 2017 Mar 28. doi: 10.1002/hed.24762.
    PubMed     Text format     Abstract available


  43. REYES-GIBBY CC, Melkonian SC, Hanna EY, Yeung SJ, et al
    Cohort study of oncologic emergencies in patients with head and neck cancer.
    Head Neck. 2017 Mar 27. doi: 10.1002/hed.24748.
    PubMed     Text format     Abstract available


  44. WANG YY, Chen YK, Hsu YL, Chiu WC, et al
    Synthetic beta-nitrostyrene derivative CYT-Rx20 as inhibitor of oral cancer cell proliferation and tumor growth through glutathione suppression and reactive oxygen species induction.
    Head Neck. 2017 Mar 27. doi: 10.1002/hed.24664.
    PubMed     Text format     Abstract available


  45. GAMA RR, Song Y, Zhang Q, Brown MC, et al
    Body mass index and prognosis in patients with head and neck cancer.
    Head Neck. 2017 Mar 21. doi: 10.1002/hed.24760.
    PubMed     Text format     Abstract available


  46. STOKES WA, Amini A, Jones BL, McDermott JD, et al
    Survival impact of induction chemotherapy in advanced head and neck cancer: A National Cancer Database analysis.
    Head Neck. 2017 Mar 16. doi: 10.1002/hed.24739.
    PubMed     Text format     Abstract available


  47. GUO T, Goldenberg D, Fakhry C
    AHNS series: Do you know your guidelines? Management of head and neck cancer in the era of human papillomavirus: Educating our patients on human papillomavirus.
    Head Neck. 2017 Mar 6. doi: 10.1002/hed.24693.
    PubMed     Text format     Abstract available


  48. BOTS WT, van den Bosch S, Zwijnenburg EM, Dijkema T, et al
    Reirradiation of head and neck cancer: Long-term disease control and toxicity.
    Head Neck. 2017 Mar 6. doi: 10.1002/hed.24733.
    PubMed     Text format     Abstract available


  49. CHAPUT A, Calais J, Robin P, Thureau S, et al
    Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
    Head Neck. 2017 Mar 6. doi: 10.1002/hed.24738.
    PubMed     Text format     Abstract available


  50. AMOILS M, Lee CS, Sunwoo J, Aasi SZ, et al
    Node-positive cutaneous squamous cell carcinoma of the head and neck: Survival, high-risk features, and adjuvant chemoradiotherapy outcomes.
    Head Neck. 2017 Mar 2. doi: 10.1002/hed.24692.
    PubMed     Text format     Abstract available


  51. PATIL VM, Noronha V, Joshi A, Ramaswamy A, et al
    Neoadjuvant chemotherapy in geriatric head and neck cancers.
    Head Neck. 2017 Mar 1. doi: 10.1002/hed.24694.
    PubMed     Text format     Abstract available


    February 2017
  52. WALLINE HM, Goudsmit CM, McHugh JB, Tang AL, et al
    Integration of high-risk human papillomavirus into cellular cancer-related genes in head and neck cancer cell lines.
    Head Neck. 2017 Feb 25. doi: 10.1002/hed.24729.
    PubMed     Text format     Abstract available


  53. ROSKO A, Birkeland A, Shuman A, Prince M, et al
    Positron emission tomography-CT prediction of occult nodal metastasis in recurrent laryngeal cancer.
    Head Neck. 2017 Feb 25. doi: 10.1002/hed.24719.
    PubMed     Text format     Abstract available


  54. BROWN TE, Wittholz K, Way M, Banks MD, et al
    Investigation of p16 status, chemotherapy regimen, and other nutrition markers for predicting gastrostomy in patients with head and neck cancer.
    Head Neck. 2017 Feb 23. doi: 10.1002/hed.24630.
    PubMed     Text format     Abstract available



  55. International Head and Neck Cancer Epidemiology Consortium: Update No. 23.
    Head Neck. 2017 Feb 23. doi: 10.1002/hed.24651.
    PubMed     Text format    


  56. BURNS CL, Ward EC, Hill AJ, Kularatna S, et al
    Randomized controlled trial of a multisite speech pathology telepractice service providing swallowing and communication intervention to patients with head and neck cancer: Evaluation of service outcomes.
    Head Neck. 2017 Feb 22. doi: 10.1002/hed.24706.
    PubMed     Text format     Abstract available


  57. AFFOLTER A, Samosny G, Heimes AS, Schneider J, et al
    Multikinase inhibitors sorafenib and sunitinib as radiosensitizers in head and neck cancer cell lines.
    Head Neck. 2017 Feb 21. doi: 10.1002/hed.24557.
    PubMed     Text format     Abstract available


  58. HIRSHOREN N, Danne J, Dixon BJ, Magarey M, et al
    Prognostic markers in metastatic cutaneous squamous cell carcinoma of the head and neck.
    Head Neck. 2017 Feb 15. doi: 10.1002/hed.24683.
    PubMed     Text format     Abstract available


  59. AGARWAL J, Krishnatry R, Chaturvedi P, Ghosh-Laskar S, et al
    Survey of return to work of head and neck cancer survivors: A report from a tertiary cancer center in India.
    Head Neck. 2017 Feb 7. doi: 10.1002/hed.24703.
    PubMed     Text format     Abstract available


  60. ENZENHOFER E, Kadletz L, Stanisz I, Kotowski U, et al
    Effect of the histone deacetylase inhibitor resminostat on head and neck squamous cell carcinoma cell lines.
    Head Neck. 2017 Feb 7. doi: 10.1002/hed.24699.
    PubMed     Text format     Abstract available


  61. TSELIS N, Karagiannis E, Kolotas C, Baghi M, et al
    Image-guided interstitial high-dose-rate brachytherapy in the treatment of inoperable recurrent head and neck malignancies: An effective option of reirradiation.
    Head Neck. 2017 Feb 7. doi: 10.1002/hed.24697.
    PubMed     Text format     Abstract available


  62. AXELSSON L, Silander E, Nyman J, Bove M, et al
    Effect of prophylactic percutaneous endoscopic gastrostomy tube on swallowing in advanced head and neck cancer: A randomized controlled study.
    Head Neck. 2017 Feb 2. doi: 10.1002/hed.24707.
    PubMed     Text format     Abstract available


    January 2017
  63. ROSCULET N, Zhou XC, Ha P, Tang M, et al
    Neutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma.
    Head Neck. 2017 Jan 11. doi: 10.1002/hed.24658.
    PubMed     Text format     Abstract available


    December 2016
  64. WANG L, Wang X, Li Y, Han S, et al
    Human papillomavirus status and the relative biological effectiveness of proton radiotherapy in head and neck cancer cells.
    Head Neck. 2016 Dec 30. doi: 10.1002/hed.24673.
    PubMed     Text format     Abstract available


  65. REPANOS C, Mirza AH, George M, Karkos PD, et al
    Timing of neck dissection in association with transoral surgery: A systematic review.
    Head Neck. 2016 Dec 29. doi: 10.1002/hed.24680.
    PubMed     Text format     Abstract available


  66. OKOYE CC, Bucher J, Tatsuoka C, Parikh SA, et al
    Cardiovascular risk and prevention in patients with head and neck cancer treated with radiotherapy.
    Head Neck. 2016 Dec 29. doi: 10.1002/hed.24646.
    PubMed     Text format     Abstract available


  67. KWON M, Kim RB, Roh JL, Lee SW, et al
    Prevalence and clinical significance of cancer cachexia based on time from treatment in advanced-stage head and neck squamous cell carcinoma.
    Head Neck. 2016 Dec 21. doi: 10.1002/hed.24672.
    PubMed     Text format     Abstract available


  68. CANNADY SB, Hatten KM, Bur AM, Brant J, et al
    Use of free tissue transfer in head and neck cancer surgery and risk of overall and serious complication(s): An American College of Surgeons-National Surgical Quality Improvement Project analysis of free tissue transfer to the head and neck.
    Head Neck. 2016 Dec 21. doi: 10.1002/hed.24669.
    PubMed     Text format     Abstract available


  69. DU XJ, Chen L, Li WF, Tang LL, et al
    Use of pretreatment serum uric acid level to predict metastasis in locally advanced nasopharyngeal carcinoma.
    Head Neck. 2016 Dec 20. doi: 10.1002/hed.24631.
    PubMed     Text format     Abstract available


  70. BALIGA S, Kabarriti R, Ohri N, Haynes-Lewis H, et al
    Stereotactic body radiotherapy for recurrent head and neck cancer: A critical review.
    Head Neck. 2016 Dec 20. doi: 10.1002/hed.24633.
    PubMed     Text format     Abstract available


  71. MILLER MC, Goldenberg D
    AHNS Series: Do you know your guidelines? Principles of surgery for head and neck cancer: A review of the National Comprehensive Cancer Network guidelines.
    Head Neck. 2016 Dec 16. doi: 10.1002/hed.24654.
    PubMed     Text format     Abstract available


    November 2016
  72. HAAPANIEMI A, Vaisanen J, Atula T, Alho OP, et al
    Predictive factors and treatment outcome of laryngeal carcinoma recurrence.
    Head Neck. 2016 Nov 30. doi: 10.1002/hed.24642.
    PubMed     Text format     Abstract available


  73. CHAN OS, Sze HC, Lee MC, Chan LL, et al
    Reirradiation with intensity-modulated radiotherapy for locally recurrent T3 to T4 nasopharyngeal carcinoma.
    Head Neck. 2016 Nov 29. doi: 10.1002/hed.24645.
    PubMed     Text format     Abstract available



  74. International Head and Neck Cancer Epidemiology Consortium: Update No. 22.
    Head Neck. 2016 Nov 25. doi: 10.1002/hed.24510.
    PubMed     Text format    


  75. MATSUMOTO Y, Sakurai H, Kogashiwa Y, Kimura T, et al
    Inhibition of epithelial-mesenchymal transition by cetuximab via the EGFR-GEP100-Arf6-AMAP1 pathway in head and neck cancer.
    Head Neck. 2016 Nov 23. doi: 10.1002/hed.24626.
    PubMed     Text format     Abstract available


  76. ROERINK SH, Coolen L, Schenning ME, Husson O, et al
    High prevalence of self-reported shoulder complaints after thyroid carcinoma surgery.
    Head Neck. 2016 Nov 12. doi: 10.1002/hed.24579.
    PubMed     Text format     Abstract available


  77. BECK TN, Smith CH, Flieder DB, Galloway TJ, et al
    Head and neck squamous cell carcinoma: Ambiguous human papillomavirus status, elevated p16, and deleted retinoblastoma 1.
    Head Neck. 2016 Nov 8. doi: 10.1002/hed.24604.
    PubMed     Text format     Abstract available


    October 2016
  78. FARRELL E, Heffron C, Murphy M, O'Leary G, et al
    Impact of lymphocytic thyroiditis on incidence of pathological incidental thyroid carcinoma.
    Head Neck. 2016 Oct 28. doi: 10.1002/hed.24544.
    PubMed     Text format     Abstract available


  79. VAN LIEW JR, Brock RL, Christensen AJ, Karnell LH, et al
    Weight loss after head and neck cancer: A dynamic relationship with depressive symptoms.
    Head Neck. 2016 Oct 5. doi: 10.1002/hed.24601.
    PubMed     Text format     Abstract available


  80. LEE JH, Shin HJ, Yoon JH, Kim EK, et al
    Predicting lymph node metastasis in patients with papillary thyroid carcinoma by vascular index on power Doppler ultrasound.
    Head Neck. 2016 Oct 5. doi: 10.1002/hed.24592.
    PubMed     Text format     Abstract available


  81. YALNIZ Z, Demokan S, Karabulut B, Ulusan M, et al
    Copy number profiling of tumor suppressor genes in head and neck cancer.
    Head Neck. 2016 Oct 3. doi: 10.1002/hed.24593.
    PubMed     Text format     Abstract available


  82. CHEN WC, Lai CH, Chuang HC, Lin PY, et al
    Inflammation-induced myeloid-derived suppressor cells associated with squamous cell carcinoma of the head and neck.
    Head Neck. 2016 Oct 3. doi: 10.1002/hed.24595.
    PubMed     Text format     Abstract available


    September 2016
  83. CHUNG CH, Germain A, Subramaniam RM, Heilmann AM, et al
    Genomic alterations in human epidermal growth factor receptor 2 (HER2/ERBB2) in head and neck squamous cell carcinoma.
    Head Neck. 2016 Sep 21. doi: 10.1002/hed.24587.
    PubMed     Text format     Abstract available


  84. NOORLAG R, Boeve K, Witjes MJ, Koole R, et al
    Amplification and protein overexpression of cyclin D1: Predictor of occult nodal metastasis in early oral cancer.
    Head Neck. 2016 Sep 21. doi: 10.1002/hed.24584.
    PubMed     Text format     Abstract available


  85. ISHIMARU M, Ono S, Suzuki S, Matsui H, et al
    Artificial nutrition dependence after cetuximab versus cisplatin combined with radiotherapy for advanced head and neck cancer: A propensity score-matched analysis.
    Head Neck. 2016 Sep 16. doi: 10.1002/hed.24583.
    PubMed     Text format     Abstract available


  86. XU P, Min Y, Blanchard P, Feng M, et al
    Incidence of small lymph node metastases in patients with nasopharyngeal carcinoma: Clinical implications for prognosis and treatment.
    Head Neck. 2016 Sep 14. doi: 10.1002/hed.24586.
    PubMed     Text format     Abstract available


  87. LEE YB, Cho YY, Jang JY, Kim TH, et al
    Current status and diagnostic values of the Bethesda system for reporting thyroid cytopathology in a papillary thyroid carcinoma-prevalent area.
    Head Neck. 2016 Sep 12. doi: 10.1002/hed.24578.
    PubMed     Text format     Abstract available


  88. KANO S, Homma A, Hatakeyama H, Mizumachi T, et al
    Pretreatment lymphocyte-to-monocyte ratio as an independent prognostic factor for head and neck cancer.
    Head Neck. 2016 Sep 12. doi: 10.1002/hed.24576.
    PubMed     Text format     Abstract available


    August 2016
  89. POPOVTZER A, Burnstein H, Stemmer S, Limon D, et al
    Phase II organ-preservation trial: Concurrent cisplatin and radiotherapy for advanced laryngeal cancer after response to docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy.
    Head Neck. 2016 Aug 24. doi: 10.1002/hed.24571.
    PubMed     Text format     Abstract available


  90. VALERO C, Pardo L, Lopez M, Garcia J, et al
    Pretreatment count of peripheral neutrophils, monocytes, and lymphocytes as independent prognostic factor in patients with head and neck cancer.
    Head Neck. 2016 Aug 18. doi: 10.1002/hed.24561.
    PubMed     Text format     Abstract available


  91. BAEK SK, Lee MC, Hah JH, Ahn SH, et al
    Role of surgery in the management of anaplastic thyroid carcinoma: Korean nationwide multicenter study of 329 patients with anaplastic thyroid carcinoma, 2000 to 2012.
    Head Neck. 2016 Aug 18. doi: 10.1002/hed.24559.
    PubMed     Text format     Abstract available


  92. BOZEC A, Ebran N, Radosevic-Robin N, Chamorey E, et al
    Combination of phosphotidylinositol-3-kinase targeting with cetuximab and irradiation: A preclinical study on an orthotopic xenograft model of head and neck cancer.
    Head Neck. 2016 Aug 10. doi: 10.1002/hed.24560.
    PubMed     Text format     Abstract available


    July 2016

  93. International head and neck cancer epidemiology consortium: Update no. 21.
    Head Neck. 2016 Jul 26. doi: 10.1002/hed.24552.
    PubMed     Text format    


  94. ROVIRA A, Tornero J, Oliva M, Taberna M, et al
    Salvage surgery after head and neck squamous cell carcinoma treated with bioradiotherapy.
    Head Neck. 2016 Jul 26. doi: 10.1002/hed.24549.
    PubMed     Text format     Abstract available


  95. WAGNER JL, Kenney RM, Vazquez JA, Ghanem TA, et al
    Surgical prophylaxis with gram-negative activity for reduction of surgical site infections after microvascular reconstruction for head and neck cancer.
    Head Neck. 2016 Jul 26. doi: 10.1002/hed.24178.
    PubMed     Text format     Abstract available


  96. LAMBERT EM, Gunn GB, Gidley PW
    Effects of radiation on the temporal bone in patients with head and neck cancer.
    Head Neck. 2016 Jul 25. doi: 10.1002/hed.24267.
    PubMed     Text format     Abstract available


  97. CHANG CF, Kuo YL, Pu C, Chou YJ, et al
    Neck dissection and stroke in patients with oral cavity cancer: A population-based cohort study.
    Head Neck. 2016 Jul 20. doi: 10.1002/hed.24535.
    PubMed     Text format     Abstract available


  98. PETERSON LA, Bellile EL, Wolf GT, Virani S, et al
    Cigarette use, comorbidities, and prognosis in a prospective head and neck squamous cell carcinoma population.
    Head Neck. 2016 Jul 19. doi: 10.1002/hed.24515.
    PubMed     Text format     Abstract available


  99. GORDON SA, Reiter ER
    Effectiveness of critical care pathways for head and neck cancer surgery: A systematic review.
    Head Neck. 2016 Jul 8. doi: 10.1002/hed.24265.
    PubMed     Text format     Abstract available


  100. CHENG OT, Tamaki A, Rezaee RP, Zender CA, et al
    Laryngotracheal reconstruction with a prefabricated fasciocutaneous free flap for recurrent papillary thyroid carcinoma.
    Head Neck. 2016 Jul 4. doi: 10.1002/hed.24530.
    PubMed     Text format     Abstract available


    June 2016
  101. HAAPIO E, Kinnunen I, Airaksinen JK, Irjala H, et al
    Excessive intravenous fluid therapy in head and neck cancer surgery.
    Head Neck. 2016 Jun 14. doi: 10.1002/hed.24525.
    PubMed     Text format     Abstract available


  102. CANADAS-GARRE M, Becerra-Massare P, Moreno Casares A, Calleja-Hernandez MA, et al
    Relevance of BRAF and NRAS mutations in the primary tumor and metastases of papillary thyroid carcinomas.
    Head Neck. 2016 Jun 14. doi: 10.1002/hed.24517.
    PubMed     Text format     Abstract available


  103. JATANA KR, Balasubramanian P, McMullen KP, Lang JC, et al
    Effect of surgical intervention on circulating tumor cells in patients with squamous cell carcinoma of the head and neck using a negative enrichment technology.
    Head Neck. 2016 Jun 5. doi: 10.1002/hed.24519.
    PubMed     Text format     Abstract available


    May 2016
  104. GEIGER JL, Bauman JE, Gibson MK, Gooding WE, et al
    Phase II trial of everolimus in patients with previously treated recurrent or metastatic head and neck squamous cell carcinoma.
    Head Neck. 2016 May 27. doi: 10.1002/hed.24501.
    PubMed     Text format     Abstract available


  105. SUGIYAMA N, Takao S, Suzuki E, Kimata Y, et al
    Risk factors of thrombosis in a single method of microsurgical head and neck reconstruction: A multi-institutional study of 773 reconstructions with a free jejunal graft after total pharyngolaryngoesophagectomy for hypopharyngeal cancer.
    Head Neck. 2016 May 26. doi: 10.1002/hed.24504.
    PubMed     Text format     Abstract available


  106. PARAHYBA CJ, Ynoe Moraes F, Ramos PA, Haddad CM, et al
    Radiation dose distribution in the teeth, maxilla, and mandible of patients with oropharyngeal and nasopharyngeal tumors who were treated with intensity-modulated radiotherapy.
    Head Neck. 2016 May 25. doi: 10.1002/hed.24479.
    PubMed     Text format     Abstract available


  107. TIAN YH, Zou WH, Xiao WW, Zeng L, et al
    Oligometastases in AJCC stage IVc nasopharyngeal carcinoma: A subset with better overall survival.
    Head Neck. 2016 May 24. doi: 10.1002/hed.24345.
    PubMed     Text format     Abstract available


  108. CABANILLAS ME, Williams MD
    Letter to the Editor regarding squamoid pattern of anaplastic thyroid carcinoma, a poorly recognized entity.
    Head Neck. 2016 May 19. doi: 10.1002/hed.24503.
    PubMed     Text format    


  109. RYAN NA, Lazic D
    Reply to Letter to the Editor regarding anaplastic thyroid carcinoma.
    Head Neck. 2016 May 19. doi: 10.1002/hed.24500.
    PubMed     Text format    


    April 2016
  110. BOCHNIA M, Grabowski K, Zalewska A, Morawska-Kochman M, et al
    Angiofibrolipoma of the larynx: Case report and literature review.
    Head Neck. 2016;38:E81-3.
    PubMed     Text format     Abstract available


  111. NARWANI V, Nalamada K, Lee M, Kothari P, et al
    Readability and quality assessment of internet-based patient education materials related to laryngeal cancer.
    Head Neck. 2016;38:601-5.
    PubMed     Text format     Abstract available


  112. BUSSU F, Mura F, Micciche F, Bertino G, et al
    Oncologic outcome of hypopharyngeal carcinoma treated with different modalities at 2 different university hospitals.
    Head Neck. 2016;38:606-12.
    PubMed     Text format     Abstract available


  113. LEE HY, Cho YG, You JY, Choi BH, et al
    Traction injury of the recurrent laryngeal nerve: Results of continuous intraoperative neuromonitoring in a swine model.
    Head Neck. 2016;38:582-8.
    PubMed     Text format     Abstract available


  114. ZANDBERG DP, Liu S, Goloubeva O, Ord R, et al
    Oropharyngeal cancer as a driver of racial outcome disparities in squamous cell carcinoma of the head and neck: 10-year experience at the University of Maryland Greenebaum Cancer Center.
    Head Neck. 2016;38:564-72.
    PubMed     Text format     Abstract available


  115. WATANABE A, Taniguchi M, Kimura Y, Ito S, et al
    Efficient, effective, safe procedure to identify nonrecurrent inferior laryngeal nerve during thyroid surgery.
    Head Neck. 2016;38:573-7.
    PubMed     Text format     Abstract available


  116. DE ALMEIDA JR, Moskowitz AJ, Miles BA, Goldstein DP, et al
    Cost-effectiveness of transoral robotic surgery versus (chemo)radiotherapy for early T classification oropharyngeal carcinoma: A cost-utility analysis.
    Head Neck. 2016;38:589-600.
    PubMed     Text format     Abstract available


  117. ROBIN TP, Gan GN, Tam M, Westerly D, et al
    Safety of contralateral submandibular gland sparing in locally advanced oropharyngeal cancers: A multicenter review.
    Head Neck. 2016;38:506-11.
    PubMed     Text format     Abstract available


  118. MOHINDRA P, Urban E, Pagan JD, Geye HM, et al
    Selective omission of level V nodal coverage for patients with oropharyngeal cancer: Clinical validation of intensity-modulated radiotherapy experience and dosimetric significance.
    Head Neck. 2016;38:499-505.
    PubMed     Text format     Abstract available


  119. SCHOUTEN CS, Hakim S, Boellaard R, Bloemena E, et al
    Interaction of quantitative (18)F-FDG-PET-CT imaging parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma.
    Head Neck. 2016;38:529-35.
    PubMed     Text format     Abstract available


  120. KOTO M, Hasegawa A, Takagi R, Sasahara G, et al
    Carbon ion radiotherapy for locally advanced squamous cell carcinoma of the external auditory canal and middle ear.
    Head Neck. 2016;38:512-6.
    PubMed     Text format     Abstract available


  121. CARRILLO JF, Carrillo LC, Cano A, Ramirez-Ortega MC, et al
    Retrospective cohort study of prognostic factors in patients with oral cavity and oropharyngeal squamous cell carcinoma.
    Head Neck. 2016;38:536-41.
    PubMed     Text format     Abstract available


  122. OHBA S, Yokoyama J, Kojima M, Fujimaki M, et al
    Significant preservation of swallowing function in chemoradiotherapy for advanced head and neck cancer by prophylactic swallowing exercise.
    Head Neck. 2016;38:517-21.
    PubMed     Text format     Abstract available


    March 2016
  123. LORINCZ BB, Mockelmann N, Busch CJ, Hezel M, et al
    Automatic periodic stimulation of the vagus nerve during single-incision transaxillary robotic thyroidectomy: Feasibility, safety, and first cases.
    Head Neck. 2016;38:482-5.
    PubMed     Text format     Abstract available


  124. CHANG MT, Schwam ZG, Hajek MA, Paskhover B, et al
    Severe epistaxis due to aberrant vasculature in a patient with STAT-1 mutation.
    Head Neck. 2016;38:E68-70.
    PubMed     Text format     Abstract available


  125. ORY M, Eran A
    Synchronous parotid and nasopharyngeal Warthin tumor.
    Head Neck. 2016;38:E71-2.
    PubMed     Text format     Abstract available


  126. NOEL D, Fink DS, Kunduk M, Schexnaildre MA, et al
    Secondary tracheoesophageal puncture using transnasal esophagoscopy in gastric pull-up reconstruction after total laryngopharyngoesophagectomy.
    Head Neck. 2016;38:E61-3.
    PubMed     Text format     Abstract available


  127. LETSOLO BT, Faust H, Ekblad L, Wennerberg J, et al
    Establishment and characterization of a human papillomavirus type 16-positive tonsillar carcinoma xenograft in BALB/c nude mice.
    Head Neck. 2016;38:417-25.
    PubMed     Text format     Abstract available


  128. DODD RH, Marlow LA, Waller J
    Discussing a diagnosis of human papillomavirus oropharyngeal cancer with patients: An exploratory qualitative study of health professionals.
    Head Neck. 2016;38:394-401.
    PubMed     Text format     Abstract available


  129. ZEVALLOS JP, Mitra N, Swisher-McClure S
    Patterns of care and perioperative outcomes in transoral endoscopic surgery for oropharyngeal squamous cell carcinoma.
    Head Neck. 2016;38:402-9.
    PubMed     Text format     Abstract available


    February 2016
  130. KARATAS OF, Yuceturk B, Suer I, Yilmaz M, et al
    Role of miR-145 in human laryngeal squamous cell carcinoma.
    Head Neck. 2016;38:260-6.
    PubMed     Text format     Abstract available


  131. SPECTOR ME, Chinn SB, Bellile E, Gallagher KK, et al
    Matted nodes as a predictor of distant metastasis in advanced-stage III/IV oropharyngeal squamous cell carcinoma.
    Head Neck. 2016;38:184-90.
    PubMed     Text format     Abstract available


  132. MAZZONI E, Martini F, Corallini A, Taronna A, et al
    Serologic investigation of undifferentiated nasopharyngeal carcinoma and simian virus 40 infection.
    Head Neck. 2016;38:232-6.
    PubMed     Text format     Abstract available


  133. TOMIFUJI M, Araki K, Yamashita T, Mizokami D, et al
    Risk factors for dysphagia after transoral videolaryngoscopic surgery for laryngeal and pharyngeal cancer.
    Head Neck. 2016;38:196-201.
    PubMed     Text format     Abstract available


  134. CHUN BJ, Yoo IeR, Joo YH, Nam IC, et al
    Efficacy of 18F-fluorodeoxyglucose positron emission tomography/CT imaging for extracapsular spread of laryngeal squamous cell carcinoma.
    Head Neck. 2016;38:290-3.
    PubMed     Text format     Abstract available


  135. LIN H, Lin D, Xiong XS
    Roles of human papillomavirus infection and stathmin in the pathogenesis of sinonasal inverted papilloma.
    Head Neck. 2016;38:220-4.
    PubMed     Text format     Abstract available


  136. BUOHLIQA L, Upadhyay S, Nicolai P, Cavalieri R, et al
    Possible esthesioneuroblastoma metastasis to paranasal sinuses: Clinical report and literature review.
    Head Neck. 2016;38:E32-6.
    PubMed     Text format     Abstract available


  137. LIM SJ, Iyer NG, Ooi LL, Koong HN, et al
    Metastasectomy for metachronous pulmonary and hepatic metastases from nasopharyngeal carcinoma: Report of 6 cases and review of the literature.
    Head Neck. 2016;38:E37-40.
    PubMed     Text format     Abstract available


  138. CAMP S, Van Gerven L, Poorten VV, Nuyts S, et al
    Long-term follow-up of 123 patients with adenocarcinoma of the sinonasal tract treated with endoscopic resection and postoperative radiation therapy.
    Head Neck. 2016;38:294-300.
    PubMed     Text format     Abstract available


  139. RICH JT, Goldstein D, Haerle SK, Busato GM, et al
    Vascularized composite autograft for adult laryngotracheal stenosis and reconstruction.
    Head Neck. 2016;38:253-9.
    PubMed     Text format     Abstract available


  140. TIAN YM, Guan Y, Xiao WW, Zeng L, et al
    Long-term survival and late complications in intensity-modulated radiotherapy of locally recurrent T1 to T2 nasopharyngeal carcinoma.
    Head Neck. 2016;38:225-31.
    PubMed     Text format     Abstract available


  141. JOO YH, Cho KJ, Park JO, Nam IC, et al
    Swallowing function in patients with vertical hemipharyngolaryngectomy for hypopharyngeal squamous cell carcinoma.
    Head Neck. 2016;38:191-5.
    PubMed     Text format     Abstract available


    January 2016
  142. EVANS M, Powell N
    Reply to Letter to the Editor regarding "Sexual health in oral oncology: Breaking the news to patients with human papillomavirus-positive oropharyngeal cancer".
    Head Neck. 2016;38:157.
    PubMed     Text format    


  143. GRIFFITH RD, Simmons BJ, Falto-Aizpurua L, Nouri K, et al
    Letter to the Editor: Regarding HPV vaccination in patients who are infected with an oncogenic subtype.
    Head Neck. 2016;38:156.
    PubMed     Text format    


    August 2015
  144. TSAI MC, Shu YC, Hsu CC, Lin CK, et al
    False-positive finding of retropharyngeal lymph node recurrence in both fluorine FDG PET and MRI in a patient with nasopharyngeal carcinoma.
    Head Neck. 2015 Aug 28. doi: 10.1002/hed.24205.
    PubMed     Text format     Abstract available


  145. KHOR LK, Loi HY, Sinha AK, Tong KT, et al
    Ga-DOTA-peptide: A novel molecular biomarker for nasopharyngeal carcinoma.
    Head Neck. 2015 Aug 14. doi: 10.1002/hed.24164.
    PubMed     Text format     Abstract available


    December 2014
  146. NOEL CW, Foreman A, Goldstein DP, deAlmeida JR, et al
    Extent of neck dissection following transoral robotic surgical resection of oropharyngeal squamous cell carcinoma: A report of a case and potential indications for inclusion of level i in a selective neck dissection.
    Head Neck. 2014 Dec 9. doi: 10.1002/hed.23935.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Otorhinolaryngology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: